HLA-A mismatching decreased patient and graft survival (P = 0.05 and P = 0.10, respectively), but neither HLA-B or HLA-DR mismatching had an effect on survival outcomes.

We hypothesized that the wide disparity of opinion regarding the association between donor–recipient ABO mismatching and the latter outcome measures could be partially or wholly attributable to ...

Human leukocyte antigen (HLA) mismatching can reduce survival of patients with blood cancer after hematopoietic cell transplantation (HCT). How recent advances in HCT practice, in particular ...